The Therapeutic Potential of HDAC Inhibitors in the Treatment of Multiple Sclerosis

Overview of attention for article published in Molecular Medicine, February 2011

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (72nd percentile)
Above-average Attention Score compared to outputs of the same age and source (57th percentile)

Mentioned by

patent: 3 patents

Citations

dimensions_citation: 63 Dimensions

Readers on

mendeley: 72 Mendeley

Summary Patents Dimensions citations

So far, Altmetric has seen 3 patents that reference this research output.

COMPOUNDS FOR THE TREATMENT OF AUTOIMMUNE DISEASES

Application WO-2018087082-A1

World Intellectual Property Organisation (WIPO)

COMPOUNDS FOR THE TREATMENT OF AUTOIMMUNE DISEASES

Application EP-3318256-A1

European Patent Office

THE USE OF GENE EXPRESSION PROFILING AS A BIOMARKER FOR ASSESSING THE EFFICACY OF HDAC…

Application WO-2014046871-A1

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.